Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 8/2012

01.12.2012 | Editorial

Post-mortem findings in mood disorders, nightmares and therapeutic approaches of psychiatric diseases

verfasst von: Andrea Schmitt, Peter Falkai

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Excerpt

Dedicated to post-mortem studies on mood disorders in its first part, this edition opens with Bernstein et al. [1] comparing the pathomorphology of mammillary bodies in patients with major depression disorder (MDD) and bipolar I disorder (BD) to control subjects. Via assessing the mammillary body and fornix volumes, number of neurons and neuronal densities, the group found male control subjects to have significantly larger mammillary bodies compared with females. They furthermore detected a significant reduction of the left mammillary body volume in BD patients compared with those with MDD. Another study of this work group [2] focused on alterations in GABAergic neurotransmission which are assumed to play a crucial role in the pathophysiology of mood disorders. The authors found an accentuated increase in GAD-ir neuropil density in the entorhinal cortex and the hippocampus of MDD compared with BD patients and controls. Another interesting finding was the dorsolateral prefrontal cortex in BD to be the only area showing a significant decrease of GAD-ir neuropil density compared with MDD and controls. The authors suggest a diathesis of the GABAergic system in mood disorders as possibly helpful in differentiating the pathophysiology of MDD from BD. Although protein phosphorylation, involved in specific processes like cellular signaling, might add to unravel the molecular substructure of MDD, psychiatric phosphoproteome studies are rare. Martins-de-Souza et al. [3] aimed at filling this gap with a comparative phosphoproteome analysis of dorsolateral prefrontal cortex tissues in major depression using liquid chromatography mass spectrometry. They could identify more than 5,000 phosphopeptides, corresponding to ca. 800 non-redundant proteins. Compared with controls, 90 of these proteins showed differential levels of phosphorylation in MDD patients, most of them associated with synaptic transmission and cellular architecture. This might point out potential biomarker candidates and thus add to comprehend the pathophysiology of MDD. …
Literatur
1.
Zurück zum Zitat Bernstein H-G, Klix M, Dobrowolny H, Brisch R, Steiner J, Bielau H, Gos T, Bogerts B (2012) A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0300-4 Bernstein H-G, Klix M, Dobrowolny H, Brisch R, Steiner J, Bielau H, Gos T, Bogerts B (2012) A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0300-4
2.
Zurück zum Zitat Gos T, Steiner J, Bielau H, Dobrowolny H, Günther K, Mawrin C, Krzyżanowski M, Hauser R, Brisch R, Bernstein H-G, Jankowski Z, Braun K, Bogerts B (2012) Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0315-x Gos T, Steiner J, Bielau H, Dobrowolny H, Günther K, Mawrin C, Krzyżanowski M, Hauser R, Brisch R, Bernstein H-G, Jankowski Z, Braun K, Bogerts B (2012) Differences between unipolar and bipolar I depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0315-x
3.
Zurück zum Zitat Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Rahmoune H, Bahn S (2012) Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0301-3 Martins-de-Souza D, Guest PC, Vanattou-Saifoudine N, Rahmoune H, Bahn S (2012) Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0301-3
4.
Zurück zum Zitat Zilles D, Meyer J, Schneider-Axmann T, Ekawardhani S, Gruber E, Falkai P, Gruber O (2012) Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0312-0 PubMed Zilles D, Meyer J, Schneider-Axmann T, Ekawardhani S, Gruber E, Falkai P, Gruber O (2012) Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0312-0 PubMed
5.
Zurück zum Zitat Wolf RC, Thomann PA, Sambataro F, Vasic N, Schmid M, Wolf ND (2012) Orbitofrontal cortex and impulsivity in borderline personality disorder: an MRI study of baseline brain perfusion. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0303-1 Wolf RC, Thomann PA, Sambataro F, Vasic N, Schmid M, Wolf ND (2012) Orbitofrontal cortex and impulsivity in borderline personality disorder: an MRI study of baseline brain perfusion. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0303-1
6.
Zurück zum Zitat Simor P, Horváth K, Gombos F, Takács KP, Bódizs R (2012) Disturbed dreaming and sleep quality: altered sleep architecture in subjects with frequent nightmares. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0318-7 PubMed Simor P, Horváth K, Gombos F, Takács KP, Bódizs R (2012) Disturbed dreaming and sleep quality: altered sleep architecture in subjects with frequent nightmares. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0318-7 PubMed
7.
Zurück zum Zitat Hellmann-Regen J, Gertz K, Uhlemann R, Colla M, Endres M, Kronenberg G (2012) Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0309-8 PubMed Hellmann-Regen J, Gertz K, Uhlemann R, Colla M, Endres M, Kronenberg G (2012) Retinoic acid as target for local pharmacokinetic interaction with modafinil in neural cells. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0309-8 PubMed
8.
Zurück zum Zitat Ginsberg Y, Hirvikoski T, Grann M, Lindefors N (2012) Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. Eur Arch Psychiatry Clin Neurosci. doi:10.1007/s00406-012-0317-8 PubMed Ginsberg Y, Hirvikoski T, Grann M, Lindefors N (2012) Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. Eur Arch Psychiatry Clin Neurosci. doi:10.​1007/​s00406-012-0317-8 PubMed
10.
Zurück zum Zitat Correll CU, Kane JM, Manu P (2011) Obesity and coronary risk in patients treated with second-generation antipsychotics. Eur Arch Psychiatry Clin Neurosci 261:417–423PubMedCrossRef Correll CU, Kane JM, Manu P (2011) Obesity and coronary risk in patients treated with second-generation antipsychotics. Eur Arch Psychiatry Clin Neurosci 261:417–423PubMedCrossRef
Metadaten
Titel
Post-mortem findings in mood disorders, nightmares and therapeutic approaches of psychiatric diseases
verfasst von
Andrea Schmitt
Peter Falkai
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-012-0376-x

Weitere Artikel der Ausgabe 8/2012

European Archives of Psychiatry and Clinical Neuroscience 8/2012 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.